Similar Papers

Paper Title
Journal
Date
Author
Studies on air-ion-enhanced iron chlorosis I. Active and residual iron
A P Krueger ... P C Andriese
International Journal of Biometeorology | VOL. 8
A P Krueger, et. al.A P Krueger ... P C Andriese
01 Mar 1964
Diets containing naturally occurring iron or naturally occurring iron plus supplemental ferrous sulfate both maintain normal hematological status in adult dogs
Anna K. Shoveller ... Debbie Minikhiem
Journal of Food Nutrition and Metabolism | VOL. 2019
Anna K. Shoveller, et. al.Anna K. Shoveller ... Debbie Minikhiem
16 Aug 2019
Iron-sulfur distribution and its environmental significance in three typical areas of western Lake Taihu
Wu Songjun ... Zhao Yanping
Journal of Lake Sciences | VOL. 31
Wu Songjun, et. al.Wu Songjun ... Zhao Yanping
01 Jan 2019
Candida albicans has a cell-associated ferric-reductase activity which is regulated in response to levels of iron and copper.
Julie A Morrissey ... Annette M Cashmore
Microbiology (Reading, England) | VOL. 142 ( Pt 3)
Julie A Morrissey, et. al.Julie A Morrissey ... Annette M Cashmore
01 Mar 1996
View more papers

More From: Molecular Pharmaceutics

Paper Title
Journal
Date
Author
Endogenous Iron(II) Self-Enriched Fenton Nanocatalyst via FTH1 Activity Inhibition and Iron(III) Reduction for Amplified Cancer Ferroptosis Therapy
Ying Chen ... Xiangchun Shen
Molecular Pharmaceutics | VOL. -
Ying Chen, et. al.Ying Chen ... Xiangchun Shen
06 Feb 2025
Decreased Crystal Plasticity by Solvation – the Case of Levofloxacin Acesulfame
Pin-Syuan Huang ... Changquan Calvin Sun
Molecular Pharmaceutics | VOL. -
Pin-Syuan Huang, et. al.Pin-Syuan Huang ... Changquan Calvin Sun
06 Feb 2025
Value of [68Ga]Ga-PSMA-11 PET/CT in Reflecting the Intra- and Intertumor Heterogeneity of Neovascularization in Clear Cell Renal Cell Carcinoma.
Ming Zhang ... Fei Kang
Molecular pharmaceutics | VOL. -
Ming Zhang, et. al.Ming Zhang ... Fei Kang
06 Feb 2025
Voices in Molecular Pharmaceutics: Meet Professor Hristo Svilenov who Seeks to Improve Protein Therapeutics through Formulation and Advanced Characterization Techniques.
Hristo L Svilenov
Molecular pharmaceutics | VOL. -
Hristo L SvilenovHristo L Svilenov
05 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.